Compare Harley-Davidson Inc (HOG) vs Eli Lilly And Co (LLY) Price & Performance

Harley-Davidson (HOG) trades at $26.83, down 0.45% with a bullish technical signal and mixed earnings performance. The stock shows attractive valuation metrics with P/E of 14.86 and P/S of 0.72, while revenue has declined from $5.8B in 2022 to $4.5B in 2025. Recent Q2 2026 earnings beat expectations with $0.75 EPS versus $0.645 expected, though Q1 and Q4 2025 results missed targets. The company maintains a dividend payout with recent $0.1875 declaration.

Outlook remains cautious as revenue declines and margin compression continue, though valuation appears reasonable. Key risks include tariff exposure, competitive pressures, and ongoing revenue contraction. Analyst consensus targets $28.50 with mixed sentiment (27.78% Buy, 61.11% Hold). The stock offers value characteristics but faces fundamental headwinds requiring careful monitoring of turnaround execution.

Eli Lilly (LLY) trades at $1,176.69, down 1.01% on the day, amid a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 consensus. Revenue surged to $65.18B in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing growth prospects.

The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include elevated valuation multiples and competitive pressures in the pharmaceutical sector. With a consensus price target of $1,350, upside potential exists, but investors should weigh execution risks against the company's innovation pipeline.